AstraZeneca

British drugs group AstraZeneca and the University of Oxford said on Monday they will seek regulatory approval for their coronavirus vaccine after "effective" trials, in the latest potential boost to curbing the global outbreak.

The partners announced that while the vaccine showed an average 70-percent effectiveness, the level jumped to 90 percent depending on dosage.